Correlation Between Litigation Capital and Cizzle Biotechnology

Can any of the company-specific risk be diversified away by investing in both Litigation Capital and Cizzle Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Litigation Capital and Cizzle Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Litigation Capital Management and Cizzle Biotechnology Holdings, you can compare the effects of market volatilities on Litigation Capital and Cizzle Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Litigation Capital with a short position of Cizzle Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Litigation Capital and Cizzle Biotechnology.

Diversification Opportunities for Litigation Capital and Cizzle Biotechnology

-0.06

Correlation Coefficient

Litigation Capital  Cizzle Biotechnology

Good diversification

The 3 months correlation between Litigation and Cizzle is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding Litigation Capital Management and Cizzle Biotechnology Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cizzle Biotechnology and Litigation Capital is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Litigation Capital Management are associated (or correlated) with Cizzle Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cizzle Biotechnology has no effect on the direction of Litigation Capital i.e., Litigation Capital and Cizzle Biotechnology go up and down completely randomly.

Pair Corralation between Litigation Capital and Cizzle Biotechnology

Assuming the 90 days trading horizon Litigation Capital is expected to generate 1.21 times less return on investment than Cizzle Biotechnology. But when comparing it to its historical volatility, Litigation Capital Management is 2.03 times less risky than Cizzle Biotechnology. It trades about 0.04 of its potential returns per unit of risk. Cizzle Biotechnology Holdings is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  145.00  in Cizzle Biotechnology Holdings on September 29, 2024 and sell it today you would earn a total of  10.00  from holding Cizzle Biotechnology Holdings or generate 6.9% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Litigation Capital Management  vs.  Cizzle Biotechnology Holdings

Litigation Capital

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Litigation Capital Management has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Litigation Capital is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.

Cizzle Biotechnology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Cizzle Biotechnology Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with Litigation Capital and Cizzle Biotechnology

The main advantage of trading using opposite Litigation Capital and Cizzle Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Litigation Capital position performs unexpectedly, Cizzle Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cizzle Biotechnology will offset losses from the drop in Cizzle Biotechnology's long position.

The idea behind Litigation Capital Management and Cizzle Biotechnology Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.